60 Degrees Pharmaceuticals reports 5.45% Lind Global stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
60 Degrees Pharmaceuticals, Inc. received a Schedule 13G from Lind Global Fund III LP, Lind Global Partners III LLC, and Jeff Easton reporting a beneficial ownership position in its common stock.
Each reporting person has sole voting and dispositive power over 191,571 shares, representing 5.45% of the common stock. Their holdings consist of 191,571 shares of common stock and 191,571 Series A Warrants plus 191,571 Series B Warrants. Due to conversion limitations in the warrants, their beneficial ownership is limited to an aggregate of 191,571 shares. The warrants include a provision that restricts conversion if it would cause the holder to beneficially own more than 4.99% of the company.
Key Figures
Key Terms
beneficial ownership financial
sole dispositive power financial
Series A Warrants financial
Series B Warrants financial
conversion limitations financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in SXTP does Lind Global Fund III report on this Schedule 13G?
How are Lind Global Fund III’s holdings in SXTP structured?
What conversion limitation applies to the SXTP warrants held by the reporting persons?
AI-generated analysis. How Rhea-AI works. Not financial advice.